Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Growth 2025-2031--LP INFORMATION, INC.

Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Growth 2025-2031

Product Code: 1539180

Industry: Medical Devices & Consumables

Published: May 13,2025

Pages: 87

Delivery Time: 2-3 business days

Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Growth 2025-2031

Product Code: 1539180

Industry: Medical Devices & Consumables

Published: May 13,2025

Pages: 87

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Extracorporeal Membrane Oxygenation Therapy (ECMO) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Extracorporeal membrane oxygenation (ECMO) is an advanced life support technology used to support patients with severe respiratory or circulatory failure. ECMO provides oxygenation and removes carbon dioxide through an extracorporeal circulation system, thereby replacing or assisting the patient's cardiopulmonary function.

United States market for Extracorporeal Membrane Oxygenation Therapy (ECMO) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Extracorporeal Membrane Oxygenation Therapy (ECMO) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Extracorporeal Membrane Oxygenation Therapy (ECMO) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Extracorporeal Membrane Oxygenation Therapy (ECMO) players cover GETINGE, Terumo, NIPRO, Medtronic, LivaNova, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Extracorporeal Membrane Oxygenation Therapy (ECMO) Industry Forecast” looks at past sales and reviews total world Extracorporeal Membrane Oxygenation Therapy (ECMO) sales in 2024, providing a comprehensive analysis by region and market sector of projected Extracorporeal Membrane Oxygenation Therapy (ECMO) sales for 2025 through 2031. With Extracorporeal Membrane Oxygenation Therapy (ECMO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Extracorporeal Membrane Oxygenation Therapy (ECMO) industry.

This Insight Report provides a comprehensive analysis of the global Extracorporeal Membrane Oxygenation Therapy (ECMO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Extracorporeal Membrane Oxygenation Therapy (ECMO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Extracorporeal Membrane Oxygenation Therapy (ECMO) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Extracorporeal Membrane Oxygenation Therapy (ECMO) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Extracorporeal Membrane Oxygenation Therapy (ECMO).

This report presents a comprehensive overview, market shares, and growth opportunities of Extracorporeal Membrane Oxygenation Therapy (ECMO) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Veinous (VA)

    Venous (VV)

    Arteriovenous (AV)

Segmentation by Application:

    Hospital

    Clinic

    Other

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    GETINGE

    Terumo

    NIPRO

    Medtronic

    LivaNova

    XENIOS AG

    ALung Technologies

    EUROSETS

    OriGen Biomedical

    MicroPort Scientific

Key Questions Addressed in this Report

What is the 10-year outlook for the global Extracorporeal Membrane Oxygenation Therapy (ECMO) market?

What factors are driving Extracorporeal Membrane Oxygenation Therapy (ECMO) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Extracorporeal Membrane Oxygenation Therapy (ECMO) market opportunities vary by end market size?

How does Extracorporeal Membrane Oxygenation Therapy (ECMO) break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Extracorporeal Membrane Oxygenation Therapy (ECMO) by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Extracorporeal Membrane Oxygenation Therapy (ECMO) by Country/Region, 2020, 2024 & 2031
    2.2 Extracorporeal Membrane Oxygenation Therapy (ECMO) Segment by Type
        2.2.1 Veinous (VA)
        2.2.2 Venous (VV)
        2.2.3 Arteriovenous (AV)
    2.3 Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type
        2.3.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Type (2020-2025)
        2.3.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sale Price by Type (2020-2025)
    2.4 Extracorporeal Membrane Oxygenation Therapy (ECMO) Segment by Application
        2.4.1 Hospital
        2.4.2 Clinic
        2.4.3 Other
    2.5 Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application
        2.5.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sale Market Share by Application (2020-2025)
        2.5.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Breakdown Data by Company
        3.1.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Annual Sales by Company (2020-2025)
        3.1.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Company (2020-2025)
    3.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Annual Revenue by Company (2020-2025)
        3.2.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Company (2020-2025)
        3.2.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Company (2020-2025)
    3.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sale Price by Company
    3.4 Key Manufacturers Extracorporeal Membrane Oxygenation Therapy (ECMO) Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Location Distribution
        3.4.2 Players Extracorporeal Membrane Oxygenation Therapy (ECMO) Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Extracorporeal Membrane Oxygenation Therapy (ECMO) by Geographic Region
    4.1 World Historic Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Geographic Region (2020-2025)
        4.1.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Country/Region (2020-2025)
        4.2.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Growth
    4.4 APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Growth
    4.5 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Growth
    4.6 Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Growth

5 Americas
    5.1 Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country
        5.1.1 Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2020-2025)
        5.1.2 Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2020-2025)
    5.2 Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2020-2025)
    5.3 Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region
        6.1.1 APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region (2020-2025)
        6.1.2 APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region (2020-2025)
    6.2 APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2020-2025)
    6.3 APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) by Country
        7.1.1 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2020-2025)
        7.1.2 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2020-2025)
    7.2 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2020-2025)
    7.3 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) by Country
        8.1.1 Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2020-2025)
    8.2 Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2020-2025)
    8.3 Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Extracorporeal Membrane Oxygenation Therapy (ECMO)
    10.3 Manufacturing Process Analysis of Extracorporeal Membrane Oxygenation Therapy (ECMO)
    10.4 Industry Chain Structure of Extracorporeal Membrane Oxygenation Therapy (ECMO)

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Extracorporeal Membrane Oxygenation Therapy (ECMO) Distributors
    11.3 Extracorporeal Membrane Oxygenation Therapy (ECMO) Customer

12 World Forecast Review for Extracorporeal Membrane Oxygenation Therapy (ECMO) by Geographic Region
    12.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size Forecast by Region
        12.1.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Forecast by Region (2026-2031)
        12.1.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Forecast by Type (2026-2031)
    12.7 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 GETINGE
        13.1.1 GETINGE Company Information
        13.1.2 GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
        13.1.3 GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 GETINGE Main Business Overview
        13.1.5 GETINGE Latest Developments
    13.2 Terumo
        13.2.1 Terumo Company Information
        13.2.2 Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
        13.2.3 Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 Terumo Main Business Overview
        13.2.5 Terumo Latest Developments
    13.3 NIPRO
        13.3.1 NIPRO Company Information
        13.3.2 NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
        13.3.3 NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 NIPRO Main Business Overview
        13.3.5 NIPRO Latest Developments
    13.4 Medtronic
        13.4.1 Medtronic Company Information
        13.4.2 Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
        13.4.3 Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Medtronic Main Business Overview
        13.4.5 Medtronic Latest Developments
    13.5 LivaNova
        13.5.1 LivaNova Company Information
        13.5.2 LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
        13.5.3 LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 LivaNova Main Business Overview
        13.5.5 LivaNova Latest Developments
    13.6 XENIOS AG
        13.6.1 XENIOS AG Company Information
        13.6.2 XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
        13.6.3 XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 XENIOS AG Main Business Overview
        13.6.5 XENIOS AG Latest Developments
    13.7 ALung Technologies
        13.7.1 ALung Technologies Company Information
        13.7.2 ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
        13.7.3 ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 ALung Technologies Main Business Overview
        13.7.5 ALung Technologies Latest Developments
    13.8 EUROSETS
        13.8.1 EUROSETS Company Information
        13.8.2 EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
        13.8.3 EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.8.4 EUROSETS Main Business Overview
        13.8.5 EUROSETS Latest Developments
    13.9 OriGen Biomedical
        13.9.1 OriGen Biomedical Company Information
        13.9.2 OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
        13.9.3 OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.9.4 OriGen Biomedical Main Business Overview
        13.9.5 OriGen Biomedical Latest Developments
    13.10 MicroPort Scientific
        13.10.1 MicroPort Scientific Company Information
        13.10.2 MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
        13.10.3 MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.10.4 MicroPort Scientific Main Business Overview
        13.10.5 MicroPort Scientific Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Extracorporeal Membrane Oxygenation Therapy (ECMO) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Extracorporeal Membrane Oxygenation Therapy (ECMO) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Veinous (VA)
 Table 4. Major Players of Venous (VV)
 Table 5. Major Players of Arteriovenous (AV)
 Table 6. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2020-2025) & (Units)
 Table 7. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Type (2020-2025)
 Table 8. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Type (2020-2025) & ($ million)
 Table 9. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Type (2020-2025)
 Table 10. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sale Price by Type (2020-2025) & (US$/Unit)
 Table 11. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sale by Application (2020-2025) & (Units)
 Table 12. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sale Market Share by Application (2020-2025)
 Table 13. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Application (2020-2025) & ($ million)
 Table 14. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Application (2020-2025)
 Table 15. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sale Price by Application (2020-2025) & (US$/Unit)
 Table 16. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Company (2020-2025) & (Units)
 Table 17. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Company (2020-2025)
 Table 18. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Company (2020-2025) & ($ millions)
 Table 19. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Company (2020-2025)
 Table 20. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sale Price by Company (2020-2025) & (US$/Unit)
 Table 21. Key Manufacturers Extracorporeal Membrane Oxygenation Therapy (ECMO) Producing Area Distribution and Sales Area
 Table 22. Players Extracorporeal Membrane Oxygenation Therapy (ECMO) Products Offered
 Table 23. Extracorporeal Membrane Oxygenation Therapy (ECMO) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 24. New Products and Potential Entrants
 Table 25. Market M&A Activity & Strategy
 Table 26. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Geographic Region (2020-2025) & (Units)
 Table 27. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share Geographic Region (2020-2025)
 Table 28. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 29. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Geographic Region (2020-2025)
 Table 30. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country/Region (2020-2025) & (Units)
 Table 31. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country/Region (2020-2025)
 Table 32. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country/Region (2020-2025) & ($ millions)
 Table 33. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Country/Region (2020-2025)
 Table 34. Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2020-2025) & (Units)
 Table 35. Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country (2020-2025)
 Table 36. Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2020-2025) & ($ millions)
 Table 37. Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2020-2025) & (Units)
 Table 38. Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2020-2025) & (Units)
 Table 39. APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Region (2020-2025) & (Units)
 Table 40. APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Region (2020-2025)
 Table 41. APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Region (2020-2025) & ($ millions)
 Table 42. APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2020-2025) & (Units)
 Table 43. APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2020-2025) & (Units)
 Table 44. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2020-2025) & (Units)
 Table 45. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Country (2020-2025) & ($ millions)
 Table 46. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2020-2025) & (Units)
 Table 47. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2020-2025) & (Units)
 Table 48. Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Country (2020-2025) & (Units)
 Table 49. Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Country (2020-2025)
 Table 50. Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Type (2020-2025) & (Units)
 Table 51. Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Application (2020-2025) & (Units)
 Table 52. Key Market Drivers & Growth Opportunities of Extracorporeal Membrane Oxygenation Therapy (ECMO)
 Table 53. Key Market Challenges & Risks of Extracorporeal Membrane Oxygenation Therapy (ECMO)
 Table 54. Key Industry Trends of Extracorporeal Membrane Oxygenation Therapy (ECMO)
 Table 55. Extracorporeal Membrane Oxygenation Therapy (ECMO) Raw Material
 Table 56. Key Suppliers of Raw Materials
 Table 57. Extracorporeal Membrane Oxygenation Therapy (ECMO) Distributors List
 Table 58. Extracorporeal Membrane Oxygenation Therapy (ECMO) Customer List
 Table 59. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Forecast by Region (2026-2031) & (Units)
 Table 60. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 61. Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Forecast by Country (2026-2031) & (Units)
 Table 62. Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 63. APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Forecast by Region (2026-2031) & (Units)
 Table 64. APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 65. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Forecast by Country (2026-2031) & (Units)
 Table 66. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 67. Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Forecast by Country (2026-2031) & (Units)
 Table 68. Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 69. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Forecast by Type (2026-2031) & (Units)
 Table 70. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 71. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Forecast by Application (2026-2031) & (Units)
 Table 72. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 73. GETINGE Basic Information, Extracorporeal Membrane Oxygenation Therapy (ECMO) Manufacturing Base, Sales Area and Its Competitors
 Table 74. GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
 Table 75. GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 76. GETINGE Main Business
 Table 77. GETINGE Latest Developments
 Table 78. Terumo Basic Information, Extracorporeal Membrane Oxygenation Therapy (ECMO) Manufacturing Base, Sales Area and Its Competitors
 Table 79. Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
 Table 80. Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Terumo Main Business
 Table 82. Terumo Latest Developments
 Table 83. NIPRO Basic Information, Extracorporeal Membrane Oxygenation Therapy (ECMO) Manufacturing Base, Sales Area and Its Competitors
 Table 84. NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
 Table 85. NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 86. NIPRO Main Business
 Table 87. NIPRO Latest Developments
 Table 88. Medtronic Basic Information, Extracorporeal Membrane Oxygenation Therapy (ECMO) Manufacturing Base, Sales Area and Its Competitors
 Table 89. Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
 Table 90. Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 91. Medtronic Main Business
 Table 92. Medtronic Latest Developments
 Table 93. LivaNova Basic Information, Extracorporeal Membrane Oxygenation Therapy (ECMO) Manufacturing Base, Sales Area and Its Competitors
 Table 94. LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
 Table 95. LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 96. LivaNova Main Business
 Table 97. LivaNova Latest Developments
 Table 98. XENIOS AG Basic Information, Extracorporeal Membrane Oxygenation Therapy (ECMO) Manufacturing Base, Sales Area and Its Competitors
 Table 99. XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
 Table 100. XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 101. XENIOS AG Main Business
 Table 102. XENIOS AG Latest Developments
 Table 103. ALung Technologies Basic Information, Extracorporeal Membrane Oxygenation Therapy (ECMO) Manufacturing Base, Sales Area and Its Competitors
 Table 104. ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
 Table 105. ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 106. ALung Technologies Main Business
 Table 107. ALung Technologies Latest Developments
 Table 108. EUROSETS Basic Information, Extracorporeal Membrane Oxygenation Therapy (ECMO) Manufacturing Base, Sales Area and Its Competitors
 Table 109. EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
 Table 110. EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 111. EUROSETS Main Business
 Table 112. EUROSETS Latest Developments
 Table 113. OriGen Biomedical Basic Information, Extracorporeal Membrane Oxygenation Therapy (ECMO) Manufacturing Base, Sales Area and Its Competitors
 Table 114. OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
 Table 115. OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 116. OriGen Biomedical Main Business
 Table 117. OriGen Biomedical Latest Developments
 Table 118. MicroPort Scientific Basic Information, Extracorporeal Membrane Oxygenation Therapy (ECMO) Manufacturing Base, Sales Area and Its Competitors
 Table 119. MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Product Portfolios and Specifications
 Table 120. MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 121. MicroPort Scientific Main Business
 Table 122. MicroPort Scientific Latest Developments


List of Figures
 Figure 1. Picture of Extracorporeal Membrane Oxygenation Therapy (ECMO)
 Figure 2. Extracorporeal Membrane Oxygenation Therapy (ECMO) Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Growth Rate 2020-2031 (Units)
 Figure 7. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country/Region (2024)
 Figure 10. Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Veinous (VA)
 Figure 12. Product Picture of Venous (VV)
 Figure 13. Product Picture of Arteriovenous (AV)
 Figure 14. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Type in 2025
 Figure 15. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Type (2020-2025)
 Figure 16. Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumed in Hospital
 Figure 17. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market: Hospital (2020-2025) & (Units)
 Figure 18. Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumed in Clinic
 Figure 19. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market: Clinic (2020-2025) & (Units)
 Figure 20. Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumed in Other
 Figure 21. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market: Other (2020-2025) & (Units)
 Figure 22. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sale Market Share by Application (2024)
 Figure 23. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Application in 2025
 Figure 24. Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales by Company in 2025 (Units)
 Figure 25. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Company in 2025
 Figure 26. Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Company in 2025 ($ millions)
 Figure 27. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Company in 2025
 Figure 28. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Geographic Region (2020-2025)
 Figure 29. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Geographic Region in 2025
 Figure 30. Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales 2020-2025 (Units)
 Figure 31. Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue 2020-2025 ($ millions)
 Figure 32. APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales 2020-2025 (Units)
 Figure 33. APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue 2020-2025 ($ millions)
 Figure 34. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales 2020-2025 (Units)
 Figure 35. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue 2020-2025 ($ millions)
 Figure 36. Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales 2020-2025 (Units)
 Figure 37. Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue 2020-2025 ($ millions)
 Figure 38. Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country in 2025
 Figure 39. Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Country (2020-2025)
 Figure 40. Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Type (2020-2025)
 Figure 41. Americas Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Application (2020-2025)
 Figure 42. United States Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 43. Canada Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 44. Mexico Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 45. Brazil Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 46. APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Region in 2025
 Figure 47. APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Region (2020-2025)
 Figure 48. APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Type (2020-2025)
 Figure 49. APAC Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Application (2020-2025)
 Figure 50. China Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 51. Japan Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 52. South Korea Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 53. Southeast Asia Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 54. India Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 55. Australia Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 56. China Taiwan Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 57. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country in 2025
 Figure 58. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share by Country (2020-2025)
 Figure 59. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Type (2020-2025)
 Figure 60. Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Application (2020-2025)
 Figure 61. Germany Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 62. France Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 63. UK Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 64. Italy Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 65. Russia Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 66. Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Country (2020-2025)
 Figure 67. Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Type (2020-2025)
 Figure 68. Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share by Application (2020-2025)
 Figure 69. Egypt Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 70. South Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 71. Israel Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 72. Turkey Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 73. GCC Countries Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Growth 2020-2025 ($ millions)
 Figure 74. Manufacturing Cost Structure Analysis of Extracorporeal Membrane Oxygenation Therapy (ECMO) in 2025
 Figure 75. Manufacturing Process Analysis of Extracorporeal Membrane Oxygenation Therapy (ECMO)
 Figure 76. Industry Chain Structure of Extracorporeal Membrane Oxygenation Therapy (ECMO)
 Figure 77. Channels of Distribution
 Figure 78. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Forecast by Region (2026-2031)
 Figure 79. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share Forecast by Region (2026-2031)
 Figure 80. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share Forecast by Type (2026-2031)
 Figure 81. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share Forecast by Type (2026-2031)
 Figure 82. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Market Share Forecast by Application (2026-2031)
 Figure 83. Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

GETINGE

Terumo

NIPRO

Medtronic

LivaNova

XENIOS AG

ALung Technologies

EUROSETS

OriGen Biomedical

MicroPort Scientific

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff